A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

CAPRIE Steering Committee - The Lancet, 1996 - Elsevier
BACKGROUND: Many clinical trials have evaluated the benefit of long-term use of
antiplatelet drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine …

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

CAPRIE Steering Committee - The Lancet, 1996 - portal.research.lu.se
BACKGROUND: Many clinical trials have evaluated the benefit of long-term use of
antiplatelet drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine …

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

CAPRIE Steering Committee - Lancet (London …, 1996 - pubmed.ncbi.nlm.nih.gov
Background Many clinical trials have evaluated the benefit of long-term use of antiplatelet
drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine have been …

[引用][C] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

D Schultz, null CAPRIE Steering Committee - Lancet, 1996 - researchnow.flinders.edu.au
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events
(CAPRIE) — Research @ Flinders Skip to main navigation Skip to search Skip to main content …